211 related articles for article (PubMed ID: 36738323)
21. Prediction of recurrence in solid nonfunctioning pituitary macroadenomas: additional benefits of diffusion-weighted MR imaging.
Ko CC; Chen TY; Lim SW; Kuo YT; Wu TC; Chen JH
J Neurosurg; 2019 Feb; 132(2):351-359. PubMed ID: 30717054
[TBL] [Abstract][Full Text] [Related]
22. Atypical pituitary adenoma: a clinicopathologic case series.
Rutkowski MJ; Alward RM; Chen R; Wagner J; Jahangiri A; Southwell DG; Kunwar S; Blevins L; Lee H; Aghi MK
J Neurosurg; 2018 Apr; 128(4):1058-1065. PubMed ID: 28598278
[TBL] [Abstract][Full Text] [Related]
23. Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection.
Juraschka K; Khan OH; Godoy BL; Monsalves E; Kilian A; Krischek B; Ghare A; Vescan A; Gentili F; Zadeh G
J Neurosurg; 2014 Jul; 121(1):75-83. PubMed ID: 24785323
[TBL] [Abstract][Full Text] [Related]
24. Giant pituitary adenomas: pathologic-radiographic correlations and lack of role for p53 and MIB-1 labeling.
Madsen H; Borges TM; Knox AJ; Michaelis KA; Xu M; Lillehei KO; Wierman ME; Kleinschmidt-DeMasters BK
Am J Surg Pathol; 2011 Aug; 35(8):1204-13. PubMed ID: 21753697
[TBL] [Abstract][Full Text] [Related]
25. Predicting Subtype of Growth Hormone Pituitary Adenoma based on Magnetic Resonance Imaging Characteristics.
Liu CX; Wang SZ; Heng LJ; Han Y; Ma YH; Yan LF; Yu Y; Wang W; Hu YC; Cui GB
J Comput Assist Tomogr; 2022 Jan-Feb 01; 46(1):124-130. PubMed ID: 35099144
[TBL] [Abstract][Full Text] [Related]
26. Ten years' experience with intraoperative MRI-assisted transsphenoidal pituitary surgery.
Hlaváč M; Knoll A; Mayer B; Braun M; Karpel-Massler G; Etzrodt-Walter G; Coburger J; Wirtz CR; Paľa A
Neurosurg Focus; 2020 Jun; 48(6):E14. PubMed ID: 32480376
[TBL] [Abstract][Full Text] [Related]
27. Biomarkers of pituitary macroadenomas aggressive behaviour: a conventional MRI and DWI 3T study.
Conficoni A; Feraco P; Mazzatenta D; Zoli M; Asioli S; Zenesini C; Fabbri VP; Cellerini M; Bacci A
Br J Radiol; 2020 Sep; 93(1113):20200321. PubMed ID: 32628097
[TBL] [Abstract][Full Text] [Related]
28. Radiomics model and clinical scale for the preoperative diagnosis of silent corticotroph adenomas.
Wang H; Chang J; Zhang W; Fang Y; Li S; Fan Y; Jiang S; Yao Y; Deng K; Lu L; Bao X; Feng F; Wang R; Feng M
J Endocrinol Invest; 2023 Sep; 46(9):1843-1854. PubMed ID: 37020103
[TBL] [Abstract][Full Text] [Related]
29. Development of a Nomogram Based on Preoperative Bi-Parametric MRI and Blood Indices for the Differentiation Between Cystic-Solid Pituitary Adenoma and Craniopharyngioma.
Zhao Z; Xiao D; Nie C; Zhang H; Jiang X; Jecha AR; Yan P; Zhao H
Front Oncol; 2021; 11():709321. PubMed ID: 34307178
[TBL] [Abstract][Full Text] [Related]
30. The Knosp Criteria Revisited: 3-Dimensional Volumetric Analysis as a Predictive Tool for Extent of Resection in Complex Endoscopic Pituitary Surgery.
DiRisio AC; Feng R; Shuman WH; Platt S; Price G; Dullea JT; Gilja S; D'Andrea MR; Delman BN; Bederson JB; Shrivastava RK
Neurosurgery; 2023 Jan; 92(1):179-185. PubMed ID: 36170168
[TBL] [Abstract][Full Text] [Related]
31. Development and Evaluation of Deep Learning-based Automated Segmentation of Pituitary Adenoma in Clinical Task.
Wang H; Zhang W; Li S; Fan Y; Feng M; Wang R
J Clin Endocrinol Metab; 2021 Aug; 106(9):2535-2546. PubMed ID: 34060609
[TBL] [Abstract][Full Text] [Related]
32. Radiologic Predictors for Extent of Resection in Pituitary Adenoma Surgery. A Single-Center Study.
Sanmillán JL; Torres-Diaz A; Sanchez-Fernández JJ; Lau R; Ciller C; Puyalto P; Gabarrós A
World Neurosurg; 2017 Dec; 108():436-446. PubMed ID: 28899832
[TBL] [Abstract][Full Text] [Related]
33. The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas.
Dai C; Liang S; Sun B; Kang J
Front Endocrinol (Lausanne); 2020; 11():608422. PubMed ID: 33362722
[TBL] [Abstract][Full Text] [Related]
34. Preoperative prediction of invasive behavior of pancreatic solid pseudopapillary neoplasm by MRI-based multiparametric radiomics models.
Liang X; He W; Huang C; Feng Z; Guan X; Liu Y; Sun Z; Li Z
Abdom Radiol (NY); 2022 Nov; 47(11):3782-3791. PubMed ID: 35976419
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
36. Intraoperative MRI in transsphenoidal resection of invasive pituitary macroadenomas.
Hlaváč M; Knoll A; Etzrodt-Walter G; Sommer F; Scheithauer M; Coburger J; Wirtz CR; Pala A
Neurosurg Rev; 2019 Sep; 42(3):737-743. PubMed ID: 30949920
[TBL] [Abstract][Full Text] [Related]
37. Pituitary macroadenoma: Accuracy of apparent diffusion coefficient magnetic resonance imaging in grading tumor aggressiveness.
Doai M; Tonami H; Matoba M; Tachibana O; Iizuka H; Nakada S; Yamada S
Neuroradiol J; 2019 Apr; 32(2):86-91. PubMed ID: 30648472
[TBL] [Abstract][Full Text] [Related]
38. The Prognostic Roles of the Ki-67 Proliferation Index, P53 Expression, Mitotic Index, and Radiological Tumor Invasion in Pituitary Adenomas.
Hasanov R; Aydoğan Bİ; Kiremitçi S; Erden E; Güllü S
Endocr Pathol; 2019 Mar; 30(1):49-55. PubMed ID: 30610566
[TBL] [Abstract][Full Text] [Related]
39. MRI radiomics for the prediction of recurrence in patients with clinically non-functioning pituitary macroadenomas.
Machado LF; Elias PCL; Moreira AC; Dos Santos AC; Murta Junior LO
Comput Biol Med; 2020 Sep; 124():103966. PubMed ID: 32860977
[TBL] [Abstract][Full Text] [Related]
40. Volumetric Study of Nonfunctioning Pituitary Adenomas: Predictors of Gross Total Resection.
Pérez-López C; Palpán AJ; Saez-Alegre M; Zamarrón Á; Alfonso C; Álvarez-Escola C; Isla A
World Neurosurg; 2021 Mar; 147():e206-e214. PubMed ID: 33309892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
